Findings from a new study suggest there may be inherent educational biases in neurocognitive screening measures of adult patients with sickle cell disease. The study, presented at the American Society of Hematology (ASH) 2020 Annual Meeting by Stéphanie Forté, MD, MSc, Department of Medicine, University Health Network, Canada, reported on the prevalence of suspected cognitive impairment in a sickle cell population using the Rowland Universal Dementia Assessment Scale (RUDAS) and Montreal Cognitive Assessment (MoCA). Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more